What amount sold does Costanoan Biotechnologies Inc. report in Form D filings?

The latest linked filings report $70K sold across 1 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Costanoan Biotechnologies Inc.'s most recent SEC filing?

Costanoan Biotechnologies Inc.'s most recent Form D filing was on 2017-01-05.

How many investors does Costanoan Biotechnologies Inc. have?

The most recent Form D filing lists 1 investor(s).

What type of securities does Costanoan Biotechnologies Inc. offer?

Costanoan Biotechnologies Inc.'s SEC Form D filings indicate debt offerings.

Costanoan Biotechnologies Inc.

CIK: 0001691297·Biotechnology·PORTLAND, OR·Corporation·Founded 2014

Reported Sold

$69,631

Total Filings

Identified Offerings

Last Filed

Jan 5, 2017

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Jan 5, 2017Form D — New notice

Reported sold: $69,631 · Target: $247,522

Section 4(a)(2)·1 investor

Fundraising Profile

Exemptions

Section 4(a)(2)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 1 identified offering

$69,631

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Tracy Thompson

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Jan 5, 2017	New	$247,522	$69,631	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

ARC Medical Inc.

Biotechnology

Offering target: $167,388

Filed Oct 9, 2026